Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Internal driving factors leading to extrahepatic manifestation of the hepatitis C virus infection.

Wu ZY, Li JR, Huang MH, Cheng JJ, Li H, Chen JH, Lv XQ, Peng ZG, Jiang JD.

Int J Mol Med. 2017 Dec;40(6):1792-1802. doi: 10.3892/ijmm.2017.3175. Epub 2017 Oct 5.

2.

Viral hijacking of host caspases: an emerging category of pathogen-host interactions.

Connolly PF, Fearnhead HO.

Cell Death Differ. 2017 Aug;24(8):1401-1410. doi: 10.1038/cdd.2017.59. Epub 2017 May 12. Review.

PMID:
28524855
3.

Hepatitis C Virus Indirectly Disrupts DNA Damage-Induced p53 Responses by Activating Protein Kinase R.

Mitchell JK, Midkiff BR, Israelow B, Evans MJ, Lanford RE, Walker CM, Lemon SM, McGivern DR.

MBio. 2017 Apr 25;8(2). pii: e00121-17. doi: 10.1128/mBio.00121-17.

4.

Drp1-mediated mitochondrial fission promotes cell proliferation through crosstalk of p53 and NF-κB pathways in hepatocellular carcinoma.

Zhan L, Cao H, Wang G, Lyu Y, Sun X, An J, Wu Z, Huang Q, Liu B, Xing J.

Oncotarget. 2016 Oct 4;7(40):65001-65011. doi: 10.18632/oncotarget.11339.

6.

Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress Response.

Dash S, Chava S, Aydin Y, Chandra PK, Ferraris P, Chen W, Balart LA, Wu T, Garry RF.

Viruses. 2016 May 23;8(5). pii: E150. doi: 10.3390/v8050150. Review.

7.

How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study.

Poortahmasebi V, Poorebrahim M, Najafi S, Jazayeri SM, Alavian SM, Arab SS, Ghavami S, Alavian SE, Rezaei Moghadam A, Amiri M.

Hepat Mon. 2016 Feb 20;16(2):e36005. doi: 10.5812/hepatmon.36005. eCollection 2016 Feb.

8.

Experimental models of hepatitis B and C - new insights and progress.

Thomas E, Liang TJ.

Nat Rev Gastroenterol Hepatol. 2016 Jun;13(6):362-74. doi: 10.1038/nrgastro.2016.37. Epub 2016 Apr 14. Review.

9.

Ankyrin Repeat Domain 1 is Up-regulated During Hepatitis C Virus Infection and Regulates Hepatitis C Virus Entry.

Than TT, Tran GV, Son K, Park EM, Kim S, Lim YS, Hwang SB.

Sci Rep. 2016 Feb 10;6:20819. doi: 10.1038/srep20819.

10.

Quantitative Proteomics Analysis of the Hepatitis C Virus Replicon High-Permissive and Low-Permissive Cell Lines.

Ye F, Xin Z, Han W, Fan J, Yin B, Wu S, Yang W, Yuan J, Qiang B, Sun W, Peng X.

PLoS One. 2015 Nov 6;10(11):e0142082. doi: 10.1371/journal.pone.0142082. eCollection 2015.

11.

Hepatitis C virus infection: establishment of chronicity and liver disease progression.

Kwon YC, Ray RB, Ray R.

EXCLI J. 2014 Aug 27;13:977-96. eCollection 2014. Review.

12.

FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.

Dixit U, Pandey AK, Liu Z, Kumar S, Neiditch MB, Klein KM, Pandey VN.

J Virol. 2015 Aug;89(15):7905-21. doi: 10.1128/JVI.00729-15. Epub 2015 May 20. Erratum in: J Virol. 2017 Nov 14;91(23 ):.

13.

Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?

Janardhan SV, Reau NS.

Hepat Med. 2015 Apr 16;7:11-20. doi: 10.2147/HMER.S79584. eCollection 2015. Review.

14.

Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer.

Alibek K, Irving S, Sautbayeva Z, Kakpenova A, Bekmurzayeva A, Baiken Y, Imangali N, Shaimerdenova M, Mektepbayeva D, Balabiyev A, Chinybayeva A.

Infect Agent Cancer. 2014 Dec 23;9:44. doi: 10.1186/1750-9378-9-44. eCollection 2014. Review.

15.

Viral carcinogenesis: factors inducing DNA damage and virus integration.

Chen Y, Williams V, Filippova M, Filippov V, Duerksen-Hughes P.

Cancers (Basel). 2014 Oct 22;6(4):2155-86. doi: 10.3390/cancers6042155. Review.

16.

Hepatitis C virus and hepatocellular carcinoma.

Kanda T, Yokosuka O, Omata M.

Biology (Basel). 2013 Jan 30;2(1):304-16. doi: 10.3390/biology2010304.

17.

Effect of hepatitis C infection on HIV-induced apoptosis.

Laskus T, Kibler KV, Chmielewski M, Wilkinson J, Adair D, Horban A, Stańczak G, Radkowski M.

PLoS One. 2013 Oct 1;8(10):e75921. doi: 10.1371/journal.pone.0075921. eCollection 2013.

18.
19.

Hepatitis C virus NS2 protein inhibits DNA damage pathway by sequestering p53 to the cytoplasm.

Bittar C, Shrivastava S, Bhanja Chowdhury J, Rahal P, Ray RB.

PLoS One. 2013 Apr 30;8(4):e62581. doi: 10.1371/journal.pone.0062581. Print 2013.

20.

Phosphorylation drives an apoptotic protein to activate antiapoptotic genes: paradigm of influenza A matrix 1 protein function.

Halder UC, Bhowmick R, Roy Mukherjee T, Nayak MK, Chawla-Sarkar M.

J Biol Chem. 2013 May 17;288(20):14554-68. doi: 10.1074/jbc.M112.447086. Epub 2013 Apr 2.

Supplemental Content

Support Center